EcoR1 Capital, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001587114

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q4 2023 · 51 positions · Total reported value $3.85B · Top-10 concentration 72.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.3% · 9 new · 5 cut · 7 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +32.8% · vs SPY +18.0% · Prev Value $2.12B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2023 13F filing, EcoR1 Capital, LLC disclosed 51 equity positions with a combined reported value of $3.85B. The filing implies a focused portfolio: its ten largest positions account for 72.2% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were APLS ($668.82M), MRTX ($434.57M), PRTA ($420.97M). By sector, the heaviest allocations are Health Care 58.3%, Materials 0.0%. Versus the prior quarter, allocation shifted toward Other (+8.9pp) and away from Health Care (-8.9pp).

Versus the prior quarter, EcoR1 Capital, LLC opened 9 new positions, trimmed 5 and fully exited 7, a turnover rate of 55.3% of positions. The portfolio's overlap with the prior quarter was 69% of names.

The largest new positions opened in Q4 2023 were ARGX ($114.51M), SRPT ($80.32M), IMNM ($41.51M).

Of the 7 positions fully exited versus the prior quarter, the largest were SWTX ($80.00M), RLAY ($35.02M), SLRN ($14.26M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • ARGX ARGENX SE · $114.51M
  • SRPT SAREPTA THERAPEUTICS INC · $80.32M
  • IMNM IMMUNOME INC · $41.51M
  • PHVS PHARVARIS N V · $25.25M
  • NGNE NEUROGENE INC COM · $24.64M
  • VERV VERVE THERAPEUTICS INC · $17.43M
  • ITOS ITEOS THERAPEUTICS INC · $12.21M
  • ATRA ATARA BIOTHERAPEUTICS INC · $5.16M

Fully Exited (vs previous quarter)

  • SWTX SPRINGWORKS THERAPEUTICS INC · prev qtr: $80.00M
  • RLAY RELAY THERAPEUTICS INC · prev qtr: $35.02M · history
  • SLRN ACELYRIN INC · prev qtr: $14.26M
  • ALLO ALLOGENE THERAPEUTICS INC · prev qtr: $14.23M
  • DCPH DECIPHERA PHARMACEUTICALS IN · prev qtr: $12.63M
  • PRME PRIME MEDICINE INC · prev qtr: $5.72M
  • PRLD PRELUDE THERAPEUTICS INC · prev qtr: $3.58M
  • TPST TEMPEST THERAPEUTICS INC · prev qtr: $283.68K

Insider Transactions (Form 4)

Latest EcoR1 Capital, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-05-07 Buy Atara Biotherapeutics, Inc. 507,407 $9.35 SEC filing
2026-04-20 Sell First Tracks Biotherapeutics, Inc. 4,705,575 $13.81 SEC filing

All insider transactions →

Fund Profile

EcoR1 Capital, LLC, based in San Francisco, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 31 positions worth $1.95B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-100470 (status: Approved), registered 2015-07-02
  • Regulatory AUM (Form ADV): $3.42B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 2 hedge funds

Portfolio Structure

  • 31 positions · $1.95B reported value (Q2 2026)
  • Top 10 holdings = 87.7% of reported value
  • Largest position: ZYME (ZYMEWORKS INC) at 30.8%
  • Average position size: $62.85M

Sector Tilt

  • Health Care 97.3%
  • Financials 0.1%
  • (classified holdings cover 97% of value)

Quarterly Activity

  • Q2 2026: 9 new, 2 added, 5 reduced, 7 exited
  • 15 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 58.3%
Materials 0.0%
Other 41.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 11.17M $668.82M 17.36%
17.36%
Add
2 7.40M $434.57M 11.28%
11.28%
Add
3 11.58M $420.97M 10.93%
10.93%
Hold
4 6.73M $276.86M 7.19%
7.19%
Add
5 5.76M $233.99M 6.08%
6.08%
Hold
6 5.99M $187.59M 4.87%
4.87%
Hold
7 7.52M $161.10M 4.18%
4.18%
Hold
8 13.44M $139.62M 3.62%
3.62%
Hold
9 13.33M $131.97M 3.43%
3.43%
Add
10 1.01M $124.72M 3.24%
3.24%
Add
11 301.00K $114.51M 2.97%
2.97%
New
12 5.28M $112.15M 2.91%
2.91%
Hold
13 5.81M $83.50M 2.17%
2.17%
Hold
14 832.91K $80.32M 2.08%
2.08%
New
15 2.01M $71.61M 1.86%
1.86%
Add
16 19.36M $44.93M 1.17%
1.17%
Hold
17 5.62M $44.73M 1.16%
1.16%
Hold
18 3.88M $41.51M 1.08%
1.08%
New
19 3.49M $38.22M 0.99%
0.99%
Hold
20 2.07M $35.32M 0.92%
0.92%
Hold
21 3.18M $34.91M 0.91%
0.91%
Add
22 3.85M $32.51M 0.84%
0.84%
Hold
23 4.06M $32.37M 0.84%
0.84%
Hold
24 3.42M $31.45M 0.82%
0.82%
Hold
25 5.00M $29.15M 0.76%
0.76%
Hold
26 19.21M $29.01M 0.75%
0.75%
Hold
27 900.00K $25.25M 0.66%
0.66%
New
28 1.27M $24.64M 0.64%
0.64%
New
29 8.54M $22.37M 0.58%
0.58%
Hold
30 7.00M $21.34M 0.55%
0.55%
Hold
31 6.12M $19.70M 0.51%
0.51%
Hold
32 887.08K $19.09M 0.50%
0.50%
Add
33 1.25M $17.43M 0.45%
0.45%
New
34 1.12M $12.21M 0.32%
0.32%
New
35 9.20M $8.39M 0.22%
0.22%
Hold
36 211.26K $6.10M 0.16%
0.16%
Reduce
37 2.98M $5.90M 0.15%
0.15%
Hold
38 10.07M $5.16M 0.13%
0.13%
New
39 6.39M $4.24M 0.11%
0.11%
Add
40 132.58K $3.80M 0.10%
0.10%
Add
41 4.60M $3.72M 0.10%
0.10%
Hold
42 2.05M $3.38M 0.09%
0.09%
Hold
43 2.39M $2.05M 0.05%
0.05%
Reduce
44 748.90K $2.04M 0.05%
0.05%
Hold
45 137.01K $1.90M 0.05%
0.05%
New
46 198.48K $1.81M 0.05%
0.05%
Reduce
47 566.88K $1.76M 0.05%
0.05%
New
48 963.33K $1.45M 0.04%
0.04%
Hold
49 66.67K $744.65K 0.02%
0.02%
Hold
50 66.67K $626.65K 0.02%
0.02%
Hold

FAQ

What did EcoR1 Capital, LLC buy in 2023-Q4?

In its 2023-Q4 13F filing, EcoR1 Capital, LLC reported 51 equity positions worth $3.85B in aggregate; its largest disclosed positions were APLS ($668.82M), MRTX ($434.57M), PRTA ($420.97M).

How large is EcoR1 Capital, LLC's portfolio?

EcoR1 Capital, LLC reported $3.85B of long equity holdings across 51 positions as of 2023-Q4. Top-10 holdings account for 72.2% of reported value.

What is EcoR1 Capital, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/ecor1-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →